Home Blog Page 93

Blog

Pharma Marketing Blog

Most popular

Pharma Facebook Pages Being Phased Out: A Good Run While It...

Pharma Guy - August 10, 2011

Answers That Won’t Matter: Critique of Lilly’s Defense of DTC Advertising

Pharma Guy - October 28, 2010

Are Doctors Avoiding Twitter Because of “Doctor Bashing”?

Pharma Guy - January 21, 2011

Pharma: The Year 2014 in Images

Pharma Guy - December 19, 2014

FDA Intern & the Quest for Social Media Guidelines

Pharma Guy - August 3, 2011

Elitist Pharmaceutical Marketing

Pharma Guy - January 7, 2011

GSK May “Step Into the [DTC] Void” to Defend Avandia

Pharma Guy - May 25, 2007

GSK, GSK, GSK: TSK, TSK, TSK!

Pharma Guy - July 25, 2013

Paula Deen & Victoza: Brilliant or Dumb?

Pharma Guy - January 28, 2012

FDA at a Mall Near You: The Manchurian Connection

Pharma Guy - August 22, 2007

1...929394...240 Page 93 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026